X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (116) 116
index medicus (102) 102
female (87) 87
male (81) 81
middle aged (72) 72
life sciences (70) 70
aged (68) 68
radiology, nuclear medicine & medical imaging (52) 52
adult (49) 49
treatment outcome (48) 48
human health and pathology (41) 41
retrospective studies (36) 36
gastroenterology & hepatology (35) 35
surgery (34) 34
liver (33) 33
medicine & public health (29) 29
aged, 80 and over (27) 27
hepatocellular carcinoma (24) 24
imaging / radiology (24) 24
nuclear medicine (22) 22
cancer (21) 21
embolization (21) 21
hépatology and gastroenterology (21) 21
ultrasound (21) 21
embolization, therapeutic - methods (20) 20
magnetic resonance imaging (20) 20
oncology (19) 19
[ sdv.mhep.heg ] life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (17) 17
abridged index medicus (17) 17
bioengineering (17) 17
imaging (16) 16
interventional radiology (16) 16
mesh : humans (16) 16
chemotherapy (15) 15
radiology (15) 15
disease (14) 14
liver cancer (14) 14
liver neoplasms - therapy (14) 14
management (14) 14
tomography, x-ray computed (14) 14
tumors (14) 14
carcinoma, hepatocellular - therapy (13) 13
cardiac & cardiovascular systems (13) 13
doxorubicin (13) 13
human necessities (13) 13
hygiene (13) 13
internal medicine (13) 13
liver neoplasms - pathology (13) 13
medical imaging (13) 13
medical or veterinary science (13) 13
prospective studies (13) 13
patients (12) 12
peripheral vascular disease (12) 12
preparations for medical, dental, or toilet purposes (12) 12
risk factors (12) 12
survival (12) 12
transarterial chemoembolization (12) 12
carcinoma, hepatocellular - pathology (11) 11
cardiology (11) 11
chemoembolization, therapeutic - methods (11) 11
diagnosis (11) 11
liver - pathology (11) 11
magnetic resonance spectroscopy (11) 11
mesh : female (11) 11
mesh : male (11) 11
[ sdv ] life sciences [q-bio] (10) 10
angiography (10) 10
contrast media (10) 10
diagnostic radiology (10) 10
gastroenterology and hepatology (10) 10
hepatic steatosis (10) 10
magnetic resonance imaging - methods (10) 10
neuroradiology (10) 10
prognosis (10) 10
resection (10) 10
specific therapeutic activity of chemical compounds ormedicinal preparations (10) 10
time factors (10) 10
chemoembolization (9) 9
embolization, therapeutic (9) 9
follow-up studies (9) 9
hepatoma (9) 9
liver neoplasms - drug therapy (9) 9
mesh : aged (9) 9
mesh : middle aged (9) 9
metastasis (9) 9
prevalence (9) 9
[ info.info-im ] computer science [cs]/medical imaging (8) 8
[ sdv.ib.ima ] life sciences [q-bio]/bioengineering/imaging (8) 8
analysis (8) 8
chemoembolization, therapeutic (8) 8
colorectal cancer (8) 8
computer science (8) 8
efficacy (8) 8
microspheres (8) 8
multivariate analysis (8) 8
portal vein (8) 8
transcatheter arterial chemoembolization (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
carcinoma (7) 7
fatty liver (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 2, pp. 244 - 254
Summary The molecular events implicated in the development of endometrial carcinosarcoma remain poorly understood. Using complementary DNA microarrays, we... 
Pathology | Lin28B | HMGA2 | Endometrial carcinosarcoma | let-7b | TRANSFORMATION | UTERINE CARCINOSARCOMAS | GENE HMGA2 | PATHOLOGY | EPITHELIAL-MESENCHYMAL TRANSITION | BREAST-CANCER | MIXED MULLERIAN TUMORS | FACTOR BORIS | CARCINOMAS | CANCER PROGRESSION | EXPRESSION | Immunohistochemistry | Oligonucleotide Array Sequence Analysis | Tissue Array Analysis | Humans | Endometrial Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | MicroRNAs - metabolism | Gene Expression Profiling | RNA-Binding Proteins | Carcinoma, Endometrioid - metabolism | DNA-Binding Proteins - metabolism | Endometrial Neoplasms - genetics | HMGA2 Protein - metabolism | Epithelial-Mesenchymal Transition | HMGA2 Protein - genetics | Biomarkers, Tumor - metabolism | Female | Cell Differentiation | Real-Time Polymerase Chain Reaction | Carcinosarcoma - pathology | Carcinoma, Endometrioid - genetics | Carcinosarcoma - metabolism | RNA, Messenger - genetics | DNA-Binding Proteins - genetics | Cell Transformation, Neoplastic | Cell Line, Tumor | RNA, Neoplasm - genetics | Endometrial Neoplasms - pathology | Biomarkers, Tumor - genetics | Carcinosarcoma - genetics | MicroRNAs - genetics | Carcinoma, Endometrioid - pathology | Antigens | DNA microarrays | Chromosomal proteins | MicroRNA | Analysis | Genes | Stem cells | Development and progression | Gene expression | Carcinogenesis | Proteins | Endometrial cancer | Kinases | Tumors | Index Medicus
Journal Article
CardioVascular and Interventional Radiology, ISSN 0174-1551, 6/2016, Volume 39, Issue 6, pp. 953 - 954
Journal Article
European Radiology, ISSN 0938-7994, 3/2011, Volume 21, Issue 3, pp. 463 - 467
Journal Article
Gut, ISSN 0017-5749, 03/2010, Volume 59, Issue 3, pp. 341 - 347
Journal Article
by Vilgrain, Valérie and Pereira, Helena and Assenat, Eric and Guiu, Boris and Ilonca, Alina Diana and Ilonca, Alina D and Pageaux, Georges-Philippe and Sibert, Annie and Bouattour, Mohamed and Lebtahi, Rachida and Allaham, Wassim and Barraud, Hélène and Laurent, Valérie and Mathias, Elodie and Bronowicki, Jean-Pierre and Tasu, Jean-Pierre and Perdrisot, Rémy and Silvain, Christine and Gerolami, René and Mundler, Olivier and Seitz, Jean-Francois and Vidal, Vincent and Aubé, Christophe and Oberti, Frédéric and Couturier, Olivier and Brenot-Rossi, Isabelle and Raoul, Jean-Luc and Sarran, Anthony and Costentin, Charlotte and Itti, Emmanuel and Luciani, Alain and Adam, René and Lewin, Maïté and Samuel, Didier and Ronot, Maxime and Dinut, Aurelia and Castera, Laurent and Chatellier, Gilles and Delhom - Christol, Elisabeth and Lonjon, Julie and Abdel-Rehim, Mohamed and Dieudonné, Arnaud and Bazin, Christophe and Chagneau-Derrode, Carine and Borentain, Patrick and Bouvier, Antoine and Vervueren, Laurent and Chalaye, Julia and Kobeiter, Hicham and Edeline, Julien and Garin, Etienne and Rolland, Yan and Archambeaud, Isabelle and Eugene, Thomas and Frampas, Eric and Cassinotto, Christophe and Guyot, Martine and Hiriart, Jean-Baptiste and Lapuyade, Bruno and Vergniol, Julien and Bachellier, Philippe and Detour, Julien and Duclos, Bernard and Greget, Michel and Habersetzer, Francois and Imperiale, Alessio and Merle, Philippe and Rode, Agnès and Morvan, Julie and Nguyen-Khac, Eric and Yzet, Thierry and Baudin, Guillaume and Chevallier, Patrick and Mahamat, Abakar and Piche, Thierry and Razzouk, Micheline and Hillon, Patrick and Loffroy, Romaric and Toubeau, Michel and Vincent, Julie and Barabino, Gabriele and Bouarioua, Nadia and Cuilleron, Muriel and Ecochard, Marie and Prevot-Bitot, Nathalie and Leroy, Vincent and Roux, Julie and Sengel, Christian and Bourcier, Valérie and Ganne-Carrie, Nathalie and Seror, Olivier and Costo, Sylvie and Dao, Thông and Pelage, Jean-Pierre and Dumortier, Jérôme and Giammarile, Francesco and Valette, Pierre-Jean and Ghazzar, Nadia and Pellerin, Olivier and Taieb, Julien and ... and SARAH Trial Grp and SARAH Trial Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1624 - 1636
Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of... 
SURVIVAL | THERAPY | ONCOLOGY | COMPETING RISK | TRANSARTERIAL CHEMOEMBOLIZATION | RADIOEMBOLIZATION | QUALITY-OF-LIFE | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Liver Neoplasms - mortality | Dose-Response Relationship, Drug | Microspheres | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Neoplasm Invasiveness - pathology | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Yttrium Radioisotopes - therapeutic use | Radiotherapy Dosage | Drug Administration Schedule | Administration, Oral | Brachytherapy - methods | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Carcinoma, Hepatocellular - radiotherapy | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Liver Neoplasms - radiotherapy | Sorafenib | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Neoplasm Staging | Rare earth metals | Antimitotic agents | Product development | Hepatoma | Comparative analysis | Radiotherapy | Antineoplastic agents | Life Sciences | Liver Neoplasms/drug therapy | Phenylurea Compounds/administration & dosage | Yttrium Radioisotopes/therapeutic use | Niacinamide/analogs & derivatives | Carcinoma, Hepatocellular/radiotherapy | Carcinoma, Hepatocellular/drug therapy | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2017, Volume 35, Issue 2, pp. 256 - 257
Journal Article
European Radiology, ISSN 0938-7994, 4/2017, Volume 27, Issue 4, pp. 1431 - 1439
Journal Article
Radiology, ISSN 0033-8419, 04/2016, Volume 279, Issue 1, pp. 327 - 328
Journal Article